COVID-19 rapid guideline: managing COVID-19 (NG191)Product type:GuidanceProgramme:NICE guidelineLast updated: 1 May 2025Published: 23 March 2021
Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 (TA878)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 1 May 2025Published: 29 March 2023